Rhopressa: payments to doctors
Payments that named Rhopressa as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $8.2M
- Providers
- 12,963
- Transactions
- 49,012
- Average per transaction
- $167
The per-transaction average — $167 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 12,963 providers the average total is $630, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Aerie Pharmaceuticals, Inc. | $5,763,887 | 70.6% |
| Alcon | $2,333,542 | 28.6% |
| Alcon Research LLC | $64,935 | 0.8% |